Get started
Crescent Biopharma, Inc.Crescent Biopharma, Inc.Crescent Biopharma, Inc.

Crescent Biopharma, Inc.

No trades
See on Supercharts
Overview
Financials
Ideas Discussions Technicals Forecast Seasonals

CBIO fundamentals

Key facts

Market capitalization—
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)—
Founded—
Employees (FY)—
CEO—
Website—
About

Crescent Biopharma, Inc. operates as a biopharmaceutical company that develops and designs small molecule therapeutics to treat cancers. The company was founded on September 19, 2024 and is headquartered in Waltham, MA.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
CBIO has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company